JFNIX
Price
$70.51
Change
-$0.13 (-0.18%)
Updated
Sep 8 closing price
Net Assets
4.28B
RCGHX
Price
$15.30
Change
+$0.03 (+0.20%)
Updated
Sep 8 closing price
Net Assets
100.11M
Interact to see
Advertisement

JFNIX vs RCGHX

Header iconJFNIX vs RCGHX Comparison
Open Charts JFNIX vs RCGHXBanner chart's image
Janus Henderson Global Life Sciences I
Price$70.51
Change-$0.13 (-0.18%)
VolumeN/A
Net Assets4.28B
Virtus KAR Health Sciences C
Price$15.30
Change+$0.03 (+0.20%)
VolumeN/A
Net Assets100.11M
JFNIX vs RCGHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JFNIX vs. RCGHX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and RCGHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.29B vs. RCGHX (100M). JFNIX pays higher dividends than RCGHX: JFNIX (0.39) vs RCGHX (0.00). JFNIX was incepted earlier than RCGHX: JFNIX (16 years) vs RCGHX (24 years). RCGHX (2.14) is less costly to investors than JFNIX (0.77). JFNIX is a more actively managed with annual turnover of: 35.00 vs. RCGHX (6.00). JFNIX (2500) and RCGHX (2500) have matching initial minimum investment requirements. JFNIX annual gain was more profitable for investors over the last year : -12.30 vs. RCGHX (-13.07). JFNIX return over 5 years is better than : 9.41 vs. RCGHX (-41.42).
JFNIXRCGHXJFNIX / RCGHX
Total Expense Ratio0.772.1436%
Annual Report Gross Expense Ratio0.772.1436%
Fund Existence16 years24 years-
Gain YTD3.852-5.028-77%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.29B100M4,285%
Annual Yield % from dividends0.390.00-
Returns for 1 year-12.30-13.0794%
Returns for 3 years11.66-19.00-61%
Returns for 5 years9.41-41.42-23%
Returns for 10 years22.02-51.87-42%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVBAX31.370.13
+0.42%
JHancock Balanced A
VCKSX10.900.02
+0.18%
Virtus KAR Small-Mid Cap Growth C
NCBVX21.61N/A
N/A
PGIM Quant Solutions Mid-Cap Val C
MCRTX60.65N/A
N/A
Morgan Stanley Insight R6
GCVTX24.91-0.05
-0.20%
Goldman Sachs Large Cp Val Insghts Inv